International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC). A new collaborative global platform for global clinical trials targeting post-COVID19 patients.

Authors

  • Maria Isabel Cavalcante Siqueira Universidade Evangélica de Goiás - UniEVANGELICA, Anápolis - GO
  • Miriã Cândida Oliveira Universidade Evangélica de Goiás - UniEVANGELICA, Anápolis - GO https://orcid.org/0000-0002-5302-1388
  • Maria Eduarda Moreira Lino Universidade Evangélica de Goiás - UniEVANGELICA, Anápolis - GO https://orcid.org/0000-0002-0210-8512
  • Shayra Kellen Arantes Souza Universidade Evangélica de Goiás - UniEVANGELICA, Anápolis - GO
  • Guilherme Augusto Moreira Silva Universidade Evangélica de Goiás - UniEVANGELICA, Anápolis - GO
  • Renata Silva Rosa Tomaz Universidade Evangélica de Goiás - UniEVANGELICA, Anápolis - GO
  • Marilúcia de Morais Carrijo Universidade Evangélica de Goiás - UniEVANGELICA, Anápolis - GO
  • Thays Lisboa Guedes Universidade Evangélica de Goiás - UniEVANGELICA, Anápolis - GO
  • Beatriz Nascimento Souza Universidade Evangélica de Goiás - UniEVANGELICA, Anápolis - GO
  • Elisângela Rosa Pereira Póvoa Universidade Evangélica de Goiás - UniEVANGELICA, Anápolis - GO
  • Rubens Rodrigues Bernardes Universidade Evangélica de Goiás - UniEVANGELICA, Anápolis - GO
  • Letícia de Souza Galvão Universidade Evangélica de Goiás - UniEVANGELICA, Anápolis - GO
  • Bianca Mendonça Reis Universidade Evangélica de Goiás - UniEVANGELICA, Anápolis - GO
  • Raphael Hélvetico Carvalho de Oliveira Diniz Universidade Evangélica de Goiás - UniEVANGELICA, Anápolis - GO
  • Diogo Marques Paulino Universidade Evangélica de Goiás - UniEVANGELICA, Anápolis - GO
  • Aline Cândido Oliveira Universidade Evangélica de Goiás - UniEVANGELICA, Anápolis - GO
  • Rodolfo de Paula Vieira Universidade Evangélica de Goiás - UniEVANGELICA, Anápolis - GO
  • Vinicius Zacarias Maldaner da Silva Universidade Evangélica de Goiás - UniEVANGELICA, Anápolis - GO
  • Sara Socorro Faria Universidade Evangélica de Goiás - UniEVANGELICA, Anápolis - GO
  • Luís Vicente Franco de Oliveira Universidade Evangélica de Goiás - UniEVANGELICA, Anápolis - GO
  • Deise Aparecida de Almeida Pires Oliveira

DOI:

https://doi.org/10.17784/mtprehabjournal.2022.20.1254

Keywords:

ISARIC, SARS-CoV-2, COVID-19, Clinical trials.

Abstract

Background: In response to the pandemic caused by COVID-19, World Health Organization (WHO), together with International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC), developed research protocols facilitating global collaboration and accelerating the understanding of the disease, to identify the potential symptoms and persistent sequelae in infected individuals, which can be used in different areas of health, that is, in primary care, at a hospital or outpatient level, both public and private. Objective: To describe the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) protocol as a new global collaborative platform for global clinical trials targeting post-COVID-19 patients. Methods: The standardized forms were developed from the COVID-19 Clinical Characterization Protocol (PCC) by the ISARIC/WHO working group composed of specialist researchers with experience in clinical research in different areas of medicine and public health, especially outbreaks and infectious diseases. Conclusion: It is expected that the creation of a database composed of different populations from all over the world will help in the characterization of risk factors, in the best form of clinical intervention and in the best prevention strategies for physical, neurological and psychosocial sequelae in the medium and long term in post-COVID-19 patients.

 

Downloads

Download data is not yet available.

Downloads

Published

2022-11-01

How to Cite

Siqueira, M. I. C., Oliveira, M. C., Moreira Lino, M. E., Souza, S. K. A., Augusto Moreira Silva, G., Silva Rosa Tomaz, R., … Aparecida de Almeida Pires Oliveira, D. (2022). International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC). A new collaborative global platform for global clinical trials targeting post-COVID19 patients. Manual Therapy, Posturology & Rehabilitation Journal, 20, 1–6. https://doi.org/10.17784/mtprehabjournal.2022.20.1254

Issue

Section

Short Communication